NCT05429515View on ClinicalTrials.gov

Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 1, 2032

Study Completion Date

December 1, 2032

Conditions
Multiple MyelomaAcute Kidney InjuryHemodiafiltration With Ultrafiltrate Regeneration (HFR)
Interventions
PROCEDURE

HFR-SUPRA

HFR-SUPRA everyday for 3 days, then 3 times/week until patients do not require dialysis.

PROCEDURE

hemodialysis

hemodialysis everyday for 3 days, then 3 times/week until patients do not require dialysis.

DRUG

Chemotherapy

chemotherapy protocol will be made by hematologists.

All Listed Sponsors
collaborator

Bellco Hoxen Medical (Shanghai) Co., Ltd

UNKNOWN

lead

Peking Union Medical College Hospital

OTHER